Logo image of TESB.BR

TESSENDERLO GROUP (TESB.BR) Stock Fundamental Analysis

EBR:TESB - BE0003555639 - Common Stock

27.7 EUR
+1.4 (+5.32%)
Last: 8/22/2025, 7:00:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to TESB. TESB was compared to 68 industry peers in the Chemicals industry. TESB has only an average score on both its financial health and profitability. TESB has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year TESB was profitable.
In the past year TESB had a positive cash flow from operations.
TESB had positive earnings in each of the past 5 years.
In the past 5 years TESB always reported a positive cash flow from operatings.
TESB.BR Yearly Net Income VS EBIT VS OCF VS FCFTESB.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

1.2 Ratios

The Return On Assets of TESB (1.46%) is comparable to the rest of the industry.
The Return On Equity of TESB (2.26%) is comparable to the rest of the industry.
TESB has a Return On Invested Capital (2.05%) which is in line with its industry peers.
TESB had an Average Return On Invested Capital over the past 3 years of 6.25%. This is in line with the industry average of 6.58%.
The last Return On Invested Capital (2.05%) for TESB is well below the 3 year average (6.25%), which needs to be investigated, but indicates that TESB had better years and this may not be a problem.
Industry RankSector Rank
ROA 1.46%
ROE 2.26%
ROIC 2.05%
ROA(3y)5.03%
ROA(5y)5.73%
ROE(3y)8.04%
ROE(5y)10.34%
ROIC(3y)6.25%
ROIC(5y)7.52%
TESB.BR Yearly ROA, ROE, ROICTESB.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

TESB has a Profit Margin (1.62%) which is in line with its industry peers.
In the last couple of years the Profit Margin of TESB has declined.
TESB has a Operating Margin of 2.41%. This is comparable to the rest of the industry: TESB outperforms 41.18% of its industry peers.
TESB's Operating Margin has declined in the last couple of years.
The Gross Margin of TESB (19.38%) is worse than 70.59% of its industry peers.
TESB's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 2.41%
PM (TTM) 1.62%
GM 19.38%
OM growth 3Y-39.29%
OM growth 5Y-20.88%
PM growth 3Y-43.63%
PM growth 5Y-21.76%
GM growth 3Y-9.65%
GM growth 5Y-5.01%
TESB.BR Yearly Profit, Operating, Gross MarginsTESB.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

6

2. Health

2.1 Basic Checks

TESB has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for TESB has been reduced compared to 1 year ago.
Compared to 5 years ago, TESB has more shares outstanding
The debt/assets ratio for TESB is higher compared to a year ago.
TESB.BR Yearly Shares OutstandingTESB.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
TESB.BR Yearly Total Debt VS Total AssetsTESB.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

TESB has an Altman-Z score of 2.06. This is not the best score and indicates that TESB is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.06, TESB perfoms like the industry average, outperforming 45.59% of the companies in the same industry.
TESB has a debt to FCF ratio of 1.69. This is a very positive value and a sign of high solvency as it would only need 1.69 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.69, TESB belongs to the top of the industry, outperforming 94.12% of the companies in the same industry.
A Debt/Equity ratio of 0.07 indicates that TESB is not too dependend on debt financing.
TESB's Debt to Equity ratio of 0.07 is amongst the best of the industry. TESB outperforms 89.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 1.69
Altman-Z 2.06
ROIC/WACC0.29
WACC7.19%
TESB.BR Yearly LT Debt VS Equity VS FCFTESB.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

TESB has a Current Ratio of 2.11. This indicates that TESB is financially healthy and has no problem in meeting its short term obligations.
TESB has a better Current ratio (2.11) than 64.71% of its industry peers.
TESB has a Quick Ratio of 1.18. This is a normal value and indicates that TESB is financially healthy and should not expect problems in meeting its short term obligations.
TESB has a Quick ratio (1.18) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 2.11
Quick Ratio 1.18
TESB.BR Yearly Current Assets VS Current LiabilitesTESB.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

4

3. Growth

3.1 Past

The earnings per share for TESB have decreased strongly by -60.46% in the last year.
TESB shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -20.75% yearly.
The Revenue has decreased by -9.58% in the past year.
TESB shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.72% yearly.
EPS 1Y (TTM)-60.46%
EPS 3Y-45.77%
EPS 5Y-20.75%
EPS Q2Q%-162.24%
Revenue 1Y (TTM)-9.58%
Revenue growth 3Y8.35%
Revenue growth 5Y8.72%
Sales Q2Q%-3.32%

3.2 Future

TESB is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.03% yearly.
TESB is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.91% yearly.
EPS Next Y39.56%
EPS Next 2Y33.42%
EPS Next 3Y11.03%
EPS Next 5YN/A
Revenue Next Year3.43%
Revenue Next 2Y3.8%
Revenue Next 3Y2.91%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
TESB.BR Yearly Revenue VS EstimatesTESB.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
TESB.BR Yearly EPS VS EstimatesTESB.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 40.74, TESB can be considered very expensive at the moment.
TESB's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 27.24. TESB is valued slightly more expensive when compared to this.
The Price/Forward Earnings ratio is 17.30, which indicates a rather expensive current valuation of TESB.
Compared to the rest of the industry, the Price/Forward Earnings ratio of TESB indicates a somewhat cheap valuation: TESB is cheaper than 60.29% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of TESB to the average of the S&P500 Index (35.82), we can say TESB is valued rather cheaply.
Industry RankSector Rank
PE 40.74
Fwd PE 17.3
TESB.BR Price Earnings VS Forward Price EarningsTESB.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of TESB indicates a rather cheap valuation: TESB is cheaper than 89.71% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, TESB is valued cheaper than 89.71% of the companies in the same industry.
Industry RankSector Rank
P/FCF 10.92
EV/EBITDA 5.51
TESB.BR Per share dataTESB.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

TESB's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.03
PEG (5Y)N/A
EPS Next 2Y33.42%
EPS Next 3Y11.03%

4

5. Dividend

5.1 Amount

TESB has a Yearly Dividend Yield of 2.00%.
Compared to an average industry Dividend Yield of 3.21, TESB has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.36, TESB has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2%

5.2 History

The dividend of TESB is nicely growing with an annual growth rate of 6.16%!
Dividend Growth(5Y)6.16%
Div Incr Years0
Div Non Decr Years2
TESB.BR Yearly Dividends per shareTESB.BR Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

126.17% of the earnings are spent on dividend by TESB. This is not a sustainable payout ratio.
The dividend of TESB is growing, but earnings are growing more, so the dividend growth is sustainable.
DP126.17%
EPS Next 2Y33.42%
EPS Next 3Y11.03%
TESB.BR Yearly Income VS Free CF VS DividendTESB.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
TESB.BR Dividend Payout.TESB.BR Dividend Payout, showing the Payout Ratio.TESB.BR Dividend Payout.PayoutRetained Earnings

TESSENDERLO GROUP

EBR:TESB (8/22/2025, 7:00:00 PM)

27.7

+1.4 (+5.32%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)08-21 2025-08-21
Earnings (Next)N/A N/A
Inst Owners5.92%
Inst Owner ChangeN/A
Ins Owners67.43%
Ins Owner ChangeN/A
Market Cap1.67B
Analysts74
Price Target27.8 (0.36%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2%
Yearly Dividend0.88
Dividend Growth(5Y)6.16%
DP126.17%
Div Incr Years0
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.17%
Revenue NY rev (3m)-1.17%
Valuation
Industry RankSector Rank
PE 40.74
Fwd PE 17.3
P/S 0.63
P/FCF 10.92
P/OCF 5
P/B 0.88
P/tB 1.06
EV/EBITDA 5.51
EPS(TTM)0.68
EY2.45%
EPS(NY)1.6
Fwd EY5.78%
FCF(TTM)2.54
FCFY9.16%
OCF(TTM)5.54
OCFY19.99%
SpS44.01
BVpS31.52
TBVpS26.21
PEG (NY)1.03
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.46%
ROE 2.26%
ROCE 2.73%
ROIC 2.05%
ROICexc 2.3%
ROICexgc 2.71%
OM 2.41%
PM (TTM) 1.62%
GM 19.38%
FCFM 5.76%
ROA(3y)5.03%
ROA(5y)5.73%
ROE(3y)8.04%
ROE(5y)10.34%
ROIC(3y)6.25%
ROIC(5y)7.52%
ROICexc(3y)6.83%
ROICexc(5y)8.71%
ROICexgc(3y)7.61%
ROICexgc(5y)9.79%
ROCE(3y)8.33%
ROCE(5y)10.06%
ROICexcg growth 3Y-43.17%
ROICexcg growth 5Y-19.86%
ROICexc growth 3Y-44.09%
ROICexc growth 5Y-20.16%
OM growth 3Y-39.29%
OM growth 5Y-20.88%
PM growth 3Y-43.63%
PM growth 5Y-21.76%
GM growth 3Y-9.65%
GM growth 5Y-5.01%
F-Score6
Asset Turnover0.9
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 1.69
Debt/EBITDA 0.49
Cap/Depr 85.39%
Cap/Sales 6.82%
Interest Coverage 7.01
Cash Conversion 121.03%
Profit Quality 356.54%
Current Ratio 2.11
Quick Ratio 1.18
Altman-Z 2.06
F-Score6
WACC7.19%
ROIC/WACC0.29
Cap/Depr(3y)86.45%
Cap/Depr(5y)81.94%
Cap/Sales(3y)5.77%
Cap/Sales(5y)5.54%
Profit Quality(3y)143.93%
Profit Quality(5y)139.31%
High Growth Momentum
Growth
EPS 1Y (TTM)-60.46%
EPS 3Y-45.77%
EPS 5Y-20.75%
EPS Q2Q%-162.24%
EPS Next Y39.56%
EPS Next 2Y33.42%
EPS Next 3Y11.03%
EPS Next 5YN/A
Revenue 1Y (TTM)-9.58%
Revenue growth 3Y8.35%
Revenue growth 5Y8.72%
Sales Q2Q%-3.32%
Revenue Next Year3.43%
Revenue Next 2Y3.8%
Revenue Next 3Y2.91%
Revenue Next 5YN/A
EBIT growth 1Y-46.88%
EBIT growth 3Y-34.22%
EBIT growth 5Y-13.98%
EBIT Next Year266.59%
EBIT Next 3Y56.25%
EBIT Next 5YN/A
FCF growth 1Y274.94%
FCF growth 3Y0.11%
FCF growth 5Y5.75%
OCF growth 1Y52.01%
OCF growth 3Y10.33%
OCF growth 5Y8.69%